Cumberland Pharmaceuticals Inc. has announced the FDA approval of a supplemental New Drug Application for its product Acetadote®. The approval pertains to a new dosing regimen that simplifies its administration by combining the first two doses into a single infusion. Acetadote is used intravenously to prevent or reduce liver damage from an overdose of acetaminophen.